Your browser doesn't support javascript.
loading
Pembrolizumab Versus Combined Chemotherapy With Gemcitabine and Paclitaxel: A Comparative Assessment of Clinical Outcomes in Patients With Platinum-refractory Advanced Urothelial Cancer.
Takemura, Ayana; Matsushita, Yuto; Tamura, Keita; Sugiyama, Takayuki; Nagata, Masao; Otsuka, Atsushi; Miyake, Hideaki.
Affiliation
  • Takemura A; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Matsushita Y; Department of Urology, Hamamatsu Medical Center, Hamamatsu, Japan.
  • Tamura K; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Sugiyama T; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Nagata M; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Otsuka A; Department of Urology, Hamamatsu Medical Center, Hamamatsu, Japan.
  • Miyake H; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
In Vivo ; 35(3): 1889-1894, 2021.
Article in En | MEDLINE | ID: mdl-33910878
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platinum / Carcinoma, Transitional Cell Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: In Vivo Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platinum / Carcinoma, Transitional Cell Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: In Vivo Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Japan